How Dismantling Welfare Continues the Legacy of Eugenics
By Audrey Farley,
The Washington Post
| 09. 17. 2019
In July, the Trump administration unveiled a plan to disqualify 3 million Americans from receiving food stamps. The proposal, which would eliminate automatic enrollment in the Supplemental Nutrition Assistance Program (SNAP) for families that receive other benefits, is just the latest measure to slash federal aid for low-income people. Critics are calling the SNAP cuts “cruel and inhumane,” warning that they will endanger the well-being of many families, who will go hungry without food assistance. The administration also supports Medicaid work requirements and lowering the poverty threshold to reduce beneficiaries.
Like previous cuts to the social safety net, this measure was preceded by a significant ($1.5 trillion) corporate tax cut, suggesting that the government is squeezing the poor to pay the rich. But welfare cuts have long served another purpose: population control.
Building on the flawed logic that providing support to the poor incentivizes poverty and encourages low-income people to reproduce to take advantage of social support, Trump touts the curtailment of SNAP as a backward way of combating poverty itself. In the past few decades, lawmakers across the political...
Related Articles
By Lucy Tu, The Atlantic | 07.11.2025
Donald Trump—who is, by his own accounting, “the fertilization president” and “the father of IVF”—wants to help Americans reproduce. During his 2024 campaign, he promised that the government or insurance companies would cover the cost of in vitro fertilization. In...
By Jared Whitlock, Endpoints News | 07.15.2025
Patient groups face a harder and unpredictable path going state-by-state to boost screening for rare but treatable conditions after the Trump administration disbanded a federal advisory committee on newborn screening.
In April, the Advisory Committee on Heritable Disorders in Newborns...
By Ben Fidler and Ned Pagliarulo, Biopharma Dive | 07.21.2025
One month ago, a 51-year-old man treated in a clinical trial with an experimental gene therapy became dangerously sick. The developer of that treatment, Sarepta Therapeutics, informed the Food and Drug Administration his case could be life-threatening.
The man died...
By Pat Duggins, Alabama Public Radio | 06.27.2025
PAT DUGGINS-- If I were to say, ‘man, have you seen the price of eggs these days?’ You're probably thinking, Oh, he's talking about inflation and the price of groceries and how it became an issue in the presidential race...